FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA ™ (clesrovimab-cfor), ...

It starts with a sniffle. A mild cough. You tell yourself it’s just a cold—babies get those, right? But make no mistake. RSV ...

The number of Australians vaccinated against influenza is "worryingly low", health experts say, as new data reveal the winter ...

The newly appointed members also include an operations professor who called for Pfizer's Covid vaccine to be withdrawn and a ...

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

People in Northern Ireland are being reminded that a potentially life-saving vaccination aimed at protecting newborns and ...

A vaccine targeting a serious respiratory illness that hits infants hard has resulted in a 75 per cent reduction in babies hospitalised with the virus.

Mr. Rosen's work has appeared in Esquire, the New York Observer, City Journal, New York Magazine, and the New York Times.

Here’s what causes colds to spread so easily, how long they are usually contagious and how they’re most commonly treated.

Embryonal tumor with multilayered rosettes (ETMR) is a rare but aggressive brain cancer that affects very young children, ...